Skip to main content

AI news

Agilent agrees to buy AI-enabled pathology software firm Proscia

Agilent and Proscia announced a signed all-cash acquisition agreement: $240 million payable at closing, with up to $30 million more tied to future milestones. The deal is subject to closing conditions and expected to close early in Agilent’s fiscal 2027. Proscia’s existing digital pathology platform supports AI-enabled workflows; the combination has not closed or produced measured joint results.

Agilent

Proscia digital pathology

Funding & Deals

Published

1 source

Primary source · Agilent · October 13, 2026

Opens Agilent in a new tab. Read it there before you rely on the summary above.

Read the original

Free, email only

Unlock the full brief free.

  • What to check before you trust this story, written down
  • Each verified source, with why it matters and who published it
  • A note whenever a source has been withdrawn
  • Thirty days of stories to browse, not seven
Continue with Google and subscribeContinue with Apple and subscribe

Continuing subscribes the email on that account to Work Worth Doing, my newsletter, the same as the form below, and unlocks every free tool in this browser. We only receive your email address. Unsubscribe in one click.

This is not an account: there is no password, and the unlock is a cookie in this browser. You also join Work Worth Doing, Demetri Panici's newsletter, every week: what I built and what changed in AI. We'll email you a link to confirm, and you can unsubscribe in one click. The same signup unlocks every free tool on the site. How your email is handled.

Already subscribed? Enter the same email to unlock this browser. You won't be signed up twice.